Allogeneic marrow transplantation patients acute myeloid leukemia first remission randomized trial irradiation randomized trial Gy versus Gy total body irradiation TBI patients acute myeloid leukemia allogeneic marrow transplantation first complete remission patients mg/kg cyclophosphamide TBI HLA-identical siblings Cyclosporine methotrexate prophylaxis acute graft-versus-host disease GVHD Thirty-four patients fractions irradiation daily days fractions days actuarial probabilities relapse-free survival patients Gy Gy probabilities relapse Gy group Gy group probabilities transplant-related mortality probability moderate acute GVHD Gy group Gy group Patients irradiation immunoprophylaxis incidence acute GVHD dose TBI probability relapse survival increased mortality relapse 